Gossamer Bio, Inc.

GOSS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$57-$180-$229-$234
Dep. & Amort.$4$4$4$5
Deferred Tax$0$0$0$0
Stock-Based Comp.$21$29$43$32
Change in WC$39-$15-$4$1
Other Non-Cash-$11$3-$0$7
Operating Cash Flow-$3-$159-$187-$189
Investing Activities
PP&E Inv.$0$0-$0-$2
Net Acquisitions$0$0-$0$0
Inv. Purchases-$495-$442-$238-$152
Inv. Sales/Matur.$524$331$238$36
Other Inv. Act.$0$0$0-$0
Investing Cash Flow$29-$111-$1-$117
Financing Activities
Debt Repay.-$13-$12-$6$0
Stock Issued$0$201$120$0
Stock Repurch.$1$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$1$3$3
Financing Cash Flow-$11$190$117$3
Forex Effect-$0$0-$1-$0
Net Chg. in Cash$14-$80-$71-$303
Supplemental Information
Beg. Cash$32$112$183$487
End Cash$46$32$112$183
Free Cash Flow-$3-$159-$188-$191
Gossamer Bio, Inc. (GOSS) Financial Statements & Key Stats | AlphaPilot